Total submissions: 6
Submitter | RCV | SCV | Clinical significance | Condition | Last evaluated | Review status | Method | Comment |
---|---|---|---|---|---|---|---|---|
Eurofins Ntd Llc |
RCV000175367 | SCV000226840 | uncertain significance | not provided | 2014-11-21 | criteria provided, single submitter | clinical testing | |
Invitae | RCV000334229 | SCV000759937 | benign | Kleefstra syndrome 1 | 2023-12-25 | criteria provided, single submitter | clinical testing | |
Ambry Genetics | RCV002314606 | SCV000847675 | likely benign | Inborn genetic diseases | 2018-03-21 | criteria provided, single submitter | clinical testing | This alteration is classified as likely benign based on a combination of the following: population frequency, intact protein function, lack of segregation with disease, co-occurrence, RNA analysis, in silico models, amino acid conservation, lack of disease association in case-control studies, and/or the mechanism of disease or impacted region is inconsistent with a known cause of pathogenicity. |
Gene |
RCV000175367 | SCV001945857 | benign | not provided | 2020-03-30 | criteria provided, single submitter | clinical testing | |
Ce |
RCV000175367 | SCV004164075 | benign | not provided | 2023-04-01 | criteria provided, single submitter | clinical testing | EHMT1: BS1, BS2 |
Prevention |
RCV003917626 | SCV004742173 | benign | EHMT1-related condition | 2019-05-18 | criteria provided, single submitter | clinical testing | This variant is classified as benign based on ACMG/AMP sequence variant interpretation guidelines (Richards et al. 2015 PMID: 25741868, with internal and published modifications). |